6919 · Caliway Biopharmaceuticals Co Ltd
78.30
TWDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
NT$119.13B
PE
180.80
EV/EBITDA
57.3
DIV Yield
0%
Payout Ratio
0%
MQV Rating
5Very Weak
As at 14/10/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- Consensus Cheap
- HALO 200
- HALO All
- HALO Small
- Near 52 Week Low
- Near Support
Key Fundamentals
EPS 3 yr Growth
-6.50%
EBITDA Margin
NaN%
Operating Cashflow
-NT$426m
Free Cash Flow Return
-4.50%
ROIC
-3.70%
Interest Coverage
NaN
Quick Ratio
109.60
Performance
52 weeks range
Low 75.1 - 188
Trade Value (12mth)
US$7,687,518.00
1 week
-2.92%
1 month
-10.63%
YTD
-50.16%
1 year
-58.54%
All time high
277.00
Additional Data
Shares Outstanding (Fully Diluted)
1,549m
HALO Sector
Healthcare
Next Company Report Date
02-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
TWD
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Very Weak
Momentum
Price
Very Weak
Earnings
Neutral
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| Yufang Ling | Individual |
| Kuihui Xu | Individual |
| Gaorong Zhang | Individual |
| Quancheng Qiu | Individual |
